IOT Stock Overview
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Innovotech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.12 |
52 Week High | CA$0.13 |
52 Week Low | CA$0.02 |
Beta | 0.88 |
1 Month Change | 20.00% |
3 Month Change | 20.00% |
1 Year Change | 20.00% |
3 Year Change | -20.00% |
5 Year Change | 71.43% |
Change since IPO | -42.86% |
Recent News & Updates
Shareholder Returns
IOT | CA Life Sciences | CA Market | |
---|---|---|---|
7D | 0% | -2.9% | -1.4% |
1Y | 20.0% | 4.0% | 11.2% |
Return vs Industry: IOT exceeded the Canadian Life Sciences industry which returned 4% over the past year.
Return vs Market: IOT exceeded the Canadian Market which returned 11.2% over the past year.
Price Volatility
IOT volatility | |
---|---|
IOT Average Weekly Movement | n/a |
Life Sciences Industry Average Movement | 6.7% |
Market Average Movement | 8.8% |
10% most volatile stocks in CA Market | 17.4% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: IOT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IOT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Craig Milne | innovotech.ca |
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.
Innovotech Inc. Fundamentals Summary
IOT fundamental statistics | |
---|---|
Market cap | CA$4.68m |
Earnings (TTM) | -CA$176.78k |
Revenue (TTM) | CA$1.24m |
3.8x
P/S Ratio-26.5x
P/E RatioIs IOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IOT income statement (TTM) | |
---|---|
Revenue | CA$1.24m |
Cost of Revenue | CA$376.92k |
Gross Profit | CA$864.00k |
Other Expenses | CA$1.04m |
Earnings | -CA$176.78k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0045 |
Gross Margin | 69.63% |
Net Profit Margin | -14.25% |
Debt/Equity Ratio | 0% |
How did IOT perform over the long term?
See historical performance and comparison